Trichostatin a inhibits corneal haze in vitro and in vivo.
about
BMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivoTopical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze.Efficacious and safe tissue-selective controlled gene therapy approaches for the cornea.Efficacy and safety of mitomycin C as an agent to treat corneal scarring in horses using an in vitro model.Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts.Isolation and cultivation of equine corneal keratocytes, fibroblasts and myofibroblasts.Vorinostat: a potent agent to prevent and treat laser-induced corneal hazeTherapeutic potential of trichostatin A to control inflammatory and fibrogenic disorders of the ocular surface.Development of ex vivo organ culture models to mimic human corneal scarringRole of transforming growth factor Beta in corneal function, biology and pathologyPolyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea.Rapamycin inhibits the production of myofibroblasts and reduces corneal scarring after photorefractive keratectomy.Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy.Halofuginone down-regulates Smad3 expression and inhibits the TGFbeta-induced expression of fibrotic markers in human corneal fibroblasts.Role of 5'TG3'-interacting factors (TGIFs) in Vorinostat (HDAC inhibitor)-mediated Corneal Fibrosis Inhibition.Corneal myofibroblast biology and pathobiology: generation, persistence, and transparency.Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo.Attenuation of corneal myofibroblast development through nanoparticle-mediated soluble transforming growth factor-β type II receptor (sTGFβRII) gene transfer.Development of a novel in vivo corneal fibrosis model in the dog.ITF2357 transactivates Id3 and regulate TGFβ/BMP7 signaling pathways to attenuate corneal fibrosis.Effect of onion extract on corneal haze suppression after air assisted lamellar keratectomy.Characterization of Inhibitor of differentiation (Id) proteins in human cornea.Epigenetic Modification Prevents Excessive Wound Healing and Scar Formation After Glaucoma Filtration Surgery.Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn.PDGFRα Is a Key Regulator of T1 and T3's Differential Effect on SMA Expression in Human Corneal Fibroblasts.Corneal Regeneration After Photorefractive Keratectomy: A Review.Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts.Effect of HDAC Inhibitors on Corneal Keratocyte Mechanical Phenotypes in 3-D Collagen Matrices.Association of histone acetylation at the ACTA2 promoter region with epithelial mesenchymal transition of lens epithelial cells.Molecular mechanisms of suberoylanilide hydroxamic acid in the inhibition of TGF-β1-mediated canine corneal fibrosis.Quantitative Analysis of Collagen Produced by Rabbit Keratocytes using Second Harmonic Generation Microscopy.KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis.Novel Combination BMP7 and HGF Gene Therapy Instigates Selective Myofibroblast Apoptosis and Reduces Corneal Haze In Vivo.Platelet-Rich Plasma Prolongs Myofibroblast Accumulation in Corneal Stroma with Incisional Wound.
P2860
Q31120997-D892E0E0-49F9-476C-A5F5-B90C3EEF5A59Q33639542-7C1A45C0-E0CE-445B-A272-198AD2F8A6FDQ33886878-BF6A401A-336B-4BD8-BE59-64C104D55348Q33997504-A775F9B8-12C3-4281-A238-5C89E14049B0Q34089515-4ADDA033-1B98-47E8-AAA1-7AC9620F6331Q34092134-00F94D39-A878-4354-A2E1-44E281B3FD88Q34183481-341BDA6D-DAA8-452E-9A9A-29F8E7589DE2Q34452923-61254A5C-A7A4-4A62-899F-1FCD9F8B0AF2Q34509341-E33E828E-A4E5-4F34-B894-48C1637F5C77Q34623130-81C211E4-4B82-4DAE-853E-FE3D2DA312EDQ34982118-D06B8158-D108-488E-9FD3-FCBEDD43D386Q35012339-7EE716E2-B4A1-4B6A-AD96-7EC5AC12DDEBQ35220955-E6FF6C29-F8F3-4CE5-8998-08D23CD09A80Q35794257-70E9CFC6-CEAD-4957-91C3-49A2A3E2CAEAQ36000612-D3259774-2A11-4314-8619-E6F42E83B78BQ36007887-62447ED0-7312-4B5A-99E8-7458B7E0F927Q36321993-3B18F556-9E87-40E4-98E3-BA1AD5308B65Q36350431-B65F689E-4E4D-49AE-9F89-4A6A69A1A34FQ36386152-872E95D2-31E4-49EC-BB0D-1A4DD9028479Q36569602-BDD3305A-3BCD-4413-AAF0-87E42DA08143Q36792228-02E62096-AD4D-485E-BABF-3680E74A244AQ36971447-117BD5A6-B3CD-4C71-9F6E-0B61BD293281Q37126439-146449C9-2A31-414C-856D-1B1AD34843E8Q37131750-0B5C8228-0DCE-4C6B-9723-F4DA57AD66AAQ37682516-6F0936A7-D033-40A1-BF2B-963B61CC766FQ38274711-08B9BB1D-DEC6-4D9B-9952-45A7F13FD242Q38466614-05C348D1-90B3-4F3C-BF03-7AC8C06A262DQ40122776-BF0999D8-7E10-4F71-8590-1E70A37414ADQ41869409-A89FCC7D-C21B-4482-9DC5-EC504CF3C3F6Q42790822-4463431C-F7AE-496E-8C25-EED128430DDDQ51253982-B6D8D58F-F53A-4D59-AD79-D44911561A52Q52648806-B62024DC-7B3E-440C-9968-2156799C5ECAQ52681170-2705723E-AE33-40D9-A710-607BFA55BCFFQ52953232-135A31CD-EF5F-4A96-AF82-EFF39B0A024B
P2860
Trichostatin a inhibits corneal haze in vitro and in vivo.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Trichostatin a inhibits corneal haze in vitro and in vivo.
@ast
Trichostatin a inhibits corneal haze in vitro and in vivo.
@en
type
label
Trichostatin a inhibits corneal haze in vitro and in vivo.
@ast
Trichostatin a inhibits corneal haze in vitro and in vivo.
@en
prefLabel
Trichostatin a inhibits corneal haze in vitro and in vivo.
@ast
Trichostatin a inhibits corneal haze in vitro and in vivo.
@en
P2093
P2860
P356
P1476
Trichostatin a inhibits corneal haze in vitro and in vivo.
@en
P2093
Ajay Sharma
John W Cowden
Maneesh M Mehan
Rajiv R Mohan
Sunilima Sinha
P2860
P304
P356
10.1167/IOVS.08-2919
P407
P577
2009-01-24T00:00:00Z